Clinical Trial Update: Efficacy and Safety of Low Energy Shock Wave Plus BotulinumToxin A in Treating Patients With Interstitial Cystitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low energy shock wave plus Botulinum Toxin A for interstitial cystitis; efficacy and safety data not yet available publicly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)
• Low energy shock wave therapy (low energy shock wave therapy)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Interstitial Cystitis | Phase 2 | Status: UNKNOWN